Popular Nigerian Actress Ify Onwuemene Dies Of Endometrial Cancer
Popular Nigerian actress Ify Onwuemene dies of endometrial cancer after battling with the sickness for a long time.
Nigerian actress Ify Onwuemene, popularly known for her role in the famous sitcom “Everyday People”, has passed on. She died on Tuesday, the 25th of May, 2021, after a long-term battle with endometrial cancer.
Her colleague, Gloria Anozie-Young, who is also an actress, announced the news of her death on her Facebook page.
“With a deep sense of loss but total submission to God Almighty, we regret to announce that IFEY ONWUEMENE has gone to be with the Lord,” Anozie-Young wrote.
“IFEY ONWUEME was diagnosed with endometrial cancer. Her womb was removed, but she has been battling the ailment for many years now.
“In 2019, even after eight sessions of chemotherapy, the doctors told her she had reached stage 4. However, we are not sure if she was given the wrong diagnosis or being treated with the wrong chemo, because she still felt pains on her upper abdomen and her tummy bloated.
“Ify spent more than N10m, being helped with donations by her fellow actors and other Nigerians. A GoFundme account was opened for her, but it did not yield much. She had to go for draining every two weeks at a cost of N280,000, but only 3 litres of liquid can be removed at a time so that her heart is not affected.
“IFEY has finally gone to rest, today 25th May 2021. May her soul rest in perfect peace. Amen.”
Anozie-Young stated that burial arrangements would be released by the family of the deceased at the appropriate time.
Endometrial cancer is a type of uterine cancer that starts in the inner lining of the uterus. This lining is called the endometrium.
According to the National Cancer Institute, an estimated 3 in 100 women will be diagnosed with uterine cancer at some point in their lives. Over 80 percent of people with uterine cancer survive for five years or longer after receiving the diagnosis early enough.
Please let us know what you think about this post in the comment section below.